Therapy for Graves' disease is not straightforward and often involves complex decision making. Long-term antithyroid drug therapy is appealing because it is nonablative, but it is not for everyone. The physician must weigh the advantages and disadvantages of antithyroid drug treatment and help the patient arrive at an individualized therapeutic strategy that is appropriate and cost-effective.
|Original language||English (US)|
|Number of pages||23|
|Journal||Endocrinology and Metabolism Clinics of North America|
|State||Published - 1998|
ASJC Scopus subject areas
Research output: Contribution to journal › Article